Global Veterinary Microbiome Market- By Product
• Phage Therapy Product
• Functional Food
o Probiotics
o Prebiotics
o Postbiotics
• Gut Health Test kits
• Microbial Proteins
• Others
Global Veterinary Microbiome Market By Application
• Pathogen Control
• Microbiome analysis
• Nutrition
Global Veterinary Microbiome Market – Animal Type
• Companion animals
o Dogs
o Cats
• Poultry
• Ruminants
• Swine
• Aquaculture
• Others
Global Veterinary Microbiome Market – By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Microbiome Market Snapshot
Chapter 4. Global Veterinary Microbiome Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2021)
4.9. Use/impact of AI on Veterinary Microbiome Market Industry Trends
4.10. Global Veterinary Microbiome Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Veterinary Microbiome Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Phage Therapy Product
5.2.2. Functional Food
5.2.2.1. Probiotics
5.2.2.2. Prebiotics
5.2.2.3. Postbiotics
5.2.3. Gut Health Test kits
5.2.4. Microbial Proteins
5.2.5. Others
Chapter 6. Veterinary Microbiome Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Pathogen Control
6.2.2. Microbiome Analysis
6.2.3. Nutrition
Chapter 7. Veterinary Microbiome Market Segmentation 3: By Animal Type, Estimates & Trend Analysis
7.1. Market Share by Animal Type, 2023 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
7.2.1. Companion animals
7.2.1.1. Dogs
7.2.1.2. Cats
7.2.2. Poultry
7.2.3. Ruminants
7.2.4. Swine
7.2.5. Aquaculture
7.2.6. Others
Chapter 8. Veterinary Microbiome Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Veterinary Microbiome Market, Regional Snapshot 2023 & 2034
8.2. North America
8.2.1. North America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.2.3. North America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
8.3. Europe
8.3.1. Europe Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.3.3. Europe Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.4.3. Asia Pacific Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
8.5. Latin America
8.5.1. Latin America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.5.3. Latin America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1.1. GCC Countries
8.6.1.1.2. Israel
8.6.1.1.3. South Africa
8.6.1.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
8.6.3. Middle East & Africa Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Veterinary Microbiome Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. CanBiocin
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. CanBiocin
9.2.3. Adisseo
9.2.4. Novus International, Inc.
9.2.5. Chr. Hansen Holding A/S
9.2.6. Evonik Industries AG
9.2.7. Land O'Lakes
9.2.8. DSM
9.2.9. Novozymes
9.2.10. Alltech
9.2.11. Kemin Industries Inc
9.2.12. Phileo (Lesaffre)
9.2.13. Lallemand Inc.
9.2.14. Phibro Animal Health Corporation
9.2.15. Proteon Pharmaceuticals S.A.
9.2.16. PhageLab
9.2.17. BaseClear BV
9.2.18. Pando Nutrition Inc.
9.2.19. Biorigin
9.2.20. Porcinotec Co., Ltd.
9.2.21. Petivity
9.2.22. AnimalBiome
9.2.23. Cargill, Incorporated
9.2.24. Cytophage Technologies Ltd
9.2.25. Hill's Pet Nutrition, Inc.
9.2.26. Leiber
9.2.27. MicroSintesis Inc.
9.2.28. NomNomNow Inc.
9.2.29. Orion Corporation
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.